European Neuropsychopharmacology

Article	Citations
Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables	259
The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves	258
Results of the COVID-19 mental health international for the general population (COMET-G) study	88
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study	72
Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience	67
Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysis	64
Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis	63
Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses	53
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice	50
Stratified psychiatry: Tomorrow's precision psychiatry?	47
Brain-immune crosstalk in the treatment of major depressive disorder	45
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials	43
Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis	39
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression	39
Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls	38
Transcranial direct current stimulation in Autism Spectrum Disorder: A systematic review and meta-analysis	37
The elephant in the room: Medication as confounder	37
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial	36
Epidemiology and costs of depressive disorder in Spain: the EPICO study	36
Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions	36
Trajectory of cognitive impairments over 1 year after COVID‐19 hospitalisation: Pattern, severity, and functional implications	35
Anterior cingulate cortex neurometabolites in bipolar disorder are influenced by mood state and medication: A meta-analysis of 1H-MRS studies	33
Predictors of serious suicidal behavior in late-life depression	33
A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders	33
Application of transcranial magnetic stimulation for major depression: Coil design and neuroanatomical variability considerations	32

Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?	31
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder	30
Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection	29
Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder	29
Precision psychiatry: Complex problems require complex solutions	27
Valproic acid exposure impairs ultrasonic communication in infant, adolescent and adult rats	27
Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study	27
Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression	26
Central levels of tryptophan metabolites in subjects with bipolar disorder	26
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response	26
Digital phenotyping and the COVID-19 pandemic: Capturing behavioral change in patients with psychiatric disorders	26
Bipolar disorder cohort studies: Crucial, but underfunded	26
Preclinical animal models of mental illnesses to translate findings from the bench to the bedside: Molecular brain mechanisms and peripheral biomarkers associated to early life stress or immune challe	26
Multi-omics data integration methods and their applications in psychiatric disorders	26
The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds	24
Comparative outcomes in electroconvulsive therapy (ECT): A naturalistic comparison between outcomes in psychosis, mania, depression, psychotic depression and catatonia	24
A proof-of-concept study of maternal immune activation mediated induction of Toll-like receptor (TLR) and inflammasome pathways leading to neuroprogressive changes and schizophrenia-like behaviours in	24
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network	24
Prevention of suicide by clozapine in mental disorders: systematic review	24
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs	23
Proinflammatory mediators and their associations with medication and comorbid traits in children and adults with ADHD	23
Suicide-related thoughts and behavior and suicide death trends during the COVID-19 in the general population of Catalonia, Spain	23
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies	23
Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique	22
Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery	22
Can we expect a rise in suicide rates after the Covid-19 pandemic outbreak?	22
GENOME-WIDE ANALYSES OF ADHD IDENTIFY 27 RISK LOCI, REFINE THE GENETIC ARCHITECTURE AND IMPLICATE SEVERAL COGNITIVE DOMAINS	21
Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig	21
EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial	21
Gray matter volume of rostral anterior cingulate cortex predicts rapid antidepressant response to ketamine	21
Maternal immune activation in rats attenuates the excitability of monoamine-secreting neurons in adult offspring in a sex-specific way	21
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study	21
A case-control study of the locus coeruleus degeneration in Alzheimer's disease	21
LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility	21
Altered miRNA landscape of the anterior cingulate cortex is associated with potential loss of key neuronal functions in depressed brain	20
Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up	20
The never-ending problem: Sample size matters	20
The polysemous concepts of psychomotricity and catatonia: A European multi-consensus perspective	20
Slower perception of time in depressed and suicidal patients	19
Shaping therapeutic trajectories in mental health: Instructive vs. permissive causality	19
Depression, antidepressants, and insulin resistance: which link?	19
Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers	19
Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases	19
Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial	19
Sex differences in the antidepressant-like potential of repeated electroconvulsive seizures in adolescent and adult rats: Regulation of the early stages of hippocampal neurogenesis	19
Cognitive heterogeneity is a key predictor of differential functional outcome in patients with bipolar disorder	19
How to reduce and stop psychiatric medication	18
Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [11C]SL25.1188	18
The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study	18
Increased thin-spine density in frontal cortex pyramidal neurons in a genetic rat model of schizophrenia-relevant features	18

Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors	18
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study	18
Gut microbiota modulates expression of genes involved in the astrocyte-neuron lactate shuttle in the hippocampus	18
Cognitive reserve in mental disorders	17
Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice	17
Sucrose preference test: A systematic review of protocols for the assessment of anhedonia in rodents	17
Differential reinforcement learning responses to positive and negative information in unmedicated individuals with depression	17
Structural and functional brain abnormalities in misophonia	17
Ayahuasca's therapeutic potential: What we know – and what not	17
Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: A promising drug repurposing for bipolar disorder treatment?	16
Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials	16
Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis	16
A diet-induced gut microbiota component and related plasma metabolites are associated with depressive-like behaviour in rats	16
Registry-based studies: What they can tell us, and what they cannot	16
Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling	16
Mood instability – A new outcome measure in randomised trials of bipolar disorder?	16
The role of metformin as a treatment for neuropsychiatric illness	15
Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study	15
Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder	14
Precision psychotherapy	14
Neuropeptide Y, calcitonin gene-related peptide, and neurokinin A in brain regions of HAB rats correlate with anxiety-like behaviours	14
Psychotropic drug utilization patterns in pregnant women with bipolar disorder: A 16-year population-based cohort study	14
Immune-related biomarkers and suicidal behaviors: A meta-analysis	14
A review and meta-analysis of gene expression profiles in suicide	14
Sex-dependent grades of haematopoietic modulation in patients with major depressive episodes are associated with suicide attempts	14
The impact of the COVID-19 pandemic on eating disorders: A paradigm for an emotional post-traumatic stress model of eating disorders	14
Neurocognitive functions in persistent negative symptoms following a first episode of psychosis	14
Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis	14
Psychotherapeutic interventions specifically developed for NSSI in adolescence: A systematic review	14
Systematic comparison of duration of untreated illness versus duration of untreated psychosis in relation to psychopathology and dysfunction in the Cavan-Monaghan first episode psychosis study (CAMFEP	14
Serum endocannabinoid levels in suicide attempters: A pilot study	14
Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats	13
Region-specific and dose-specific effects of chronic haloperidol exposure on [3H]-flumazenil and [3H]-Ro15-4513 GABAA receptor binding sites in the rat brain	13
Towards precision medicine: What are the stratification hypotheses to identify homogeneous inflammatory subgroups	13
Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise	13
EXOME SEQUENCING IN BIPOLAR DISORDER REVEALS SHARED RISK GENE AKAP11 WITH SCHIZOPHRENIA	13
Neuroscience-based nomenclature of psychotropics: Progress report	13
Neurobiology of suicide in times of social isolation and loneliness	13
Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study	13
An increase in IL-6 levels at 6-month follow-up visit is associated with SSRI-emergent suicidality in high-risk children and adolescents treated with fluoxetine	13
Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C	13
Oxytocin blood concentrations in alcohol use disorder: A cross-sectional, longitudinal, and sex-separated study	12
The effect of intranasally administered oxytocin on observed social behavior in social anxiety disorder	12
The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years	12
Well-being, resilience and post-traumatic growth in the era of Covid-19 pandemic	12
Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies	12
Suicide in the COVID-19 pandemic: What we learnt and great expectations	12
Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study	12
Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism	12
Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD	12
Polygenic risk scores in psychiatry – Large potential but still limited clinical utility	12
Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study	12
Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how?	11
Antipsychotic-induced akathisia in adults with acute schizophrenia: A systematic review and dose-response meta-analysis	11
Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up	11
Bidirectional associations between treatment-resistant depression and general medical conditions	11
Chronic exposure to glucocorticoids induces suboptimal decision-making in mice	11
Ketamine treatment upon memory retrieval reduces fear memory in marmoset monkeys	11
Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes	11
Biological markers of sex-based differences in major depressive disorder and in antidepressant response	11
Metabolic predictors for mortality among patients treated with long-term clozapine – A longitudinal study	11
Shared transethnic genetic basis of panic disorder and psychiatric and related intermediate phenotypes	11
Associations between individual depressive symptoms and immunometabolic characteristics in major depression	11
Why primary prevention often is no prevention at all	11
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs	11
Current approaches to precision medicine in psychiatry: Are we just spinning our wheels?	10
Excess resource use and costs of physical comorbidities in individuals with mental health disorders: A systematic literature review and meta-analysis	10
Psychiatry training in 42 European countries: A comparative analysis	10
Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects	10
Zopiclone to treat insomnia in older adults: A systematic review	10
The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial	10
The trajectory of emotional and non-emotional cognitive function in newly diagnosed patients with bipolar disorder and their unaffected relatives: A 16-month follow-up study	10
High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study	10
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder	10
Dysfunctional coupling of the parahippocampal cortex and inferior frontal gyrus during memory suppression in posttraumatic stress disorder	10
Lithium	10
The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations	10
Aripiprazole monotherapy as transdiagnostic intervention for the treatment of mental disorders: An umbrella review according to TRANSD criteria	10
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder	10
Emotional cognition subgroups in mood disorders: Associations with familial risk	10

Antidepressant discontinuation syndrome: A state-of-the-art clinical review	9
Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis	9
The potential of psychedelics for the treatment of Alzheimer's disease and related dementias	9
The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings	9
Self-reported neurocognitive symptoms during COVID-19 lockdown and its associated factors in a sample of psychiatric patients. Results from the BRIS-MHC study	9
Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art	9
When depression is difficult to treat	9
Neuronal and cognitive predictors of improved executive function following action-based cognitive remediation in patients with bipolar disorder	9
Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders	9
Route map for machine learning in psychiatry: Absence of bias, reproducibility, and utility	9
Promoting good mental health in the whole population: The new frontier	9
Social cognition in bipolar disorder: A proxy of psychosocial function and novel treatment target?	9
Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder	9
Toward the “helioscope” hypothesis of psychedelic therapy	9
Transcriptome profiling in adult attention-deficit hyperactivity disorder	9
Cognitive processing of infant stimuli in pregnant women with and without affective disorders and the association to postpartum depression	8
A polygenic-informed approach to a predictive EEG signature empowers antidepressant treatment prediction: A proof-of-concept study	8
Primary role for melatonin MT2 receptors in the regulation of anhedonia and circadian temperature rhythm	8
Abstinence from ethanol dependence produces concomitant cortical gray matter abnormalities, microstructural deficits and cognitive dysfunction	8
Precision psychiatry: The complexity of personalizing antipsychotic dosing	8
Neuropsychological functioning of patients with major depression or bipolar disorder comorbid to substance use disorders: A systematic review	8
Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study	8
Maternal crack cocaine use in rats leads to depressive- and anxiety-like behavior, memory impairment, and increased seizure susceptibility in the offspring	8
Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis	8
Aripiprazole vs Risperidone for the acute-phase treatment of first-episode psychosis: A 6-week randomized, flexible-dose, open-label clinical trial	8
Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis	8
Social Stress in Bipolar Disorder	8
Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransm	8
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review	8
The impact of the Covid-19 pandemic on patients with schizophrenia	8
Theory of Mind and social functioning among neuropsychiatric disorders: A transdiagnostic study	8
Autoimmune encephalitis or autoimmune psychosis?	8
Apps for mental health care: The raise of digital psychiatry	8
Longitudinal alterations in mRNA expression of the BDNF neurotrophin signaling cascade in blood correlate with changes in depression scores in patients undergoing electroconvulsive therapy	8
Reinforcement learning abnormalities in the attenuated psychosis syndrome and first episode psychosis	8
The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study	8
Factors associated with laxative use in schizophrenia patients treated with second-generation antipsychotics	8
What can lifestyle factors tell us about cognitive dysfunction in bipolar disorder?	8
Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study	8
Lithium: What can we do to overcome the discrepancies between evidence, guideline recommendations and clinical practice?	8
Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction	8
The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions	8
The physiological responses to acute stress in alcohol-dependent patients: A systematic review	8
A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder	8
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study	7
Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia	7
Involvement of nicotinic acetylcholine receptors in behavioral abnormalities and psychological dependence in schizophrenia-like model mice	7
Maternal ADHD medication use during pregnancy and the risk of ADHD in children: Importance of genetic predispositions and impact of using a sibling analysis	7
A systematic review of manic/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugs	7
Classification of first-episode psychosis using cortical thickness: A large multicenter MRI study	7
Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study	7
Different baseline physical activity predicts susceptibility and resilience to chronic social defeat stress in mice: Involvement of dopamine neurons	7
Minor physical anomalies in bipolar disorder in comparison to healthy controls and schizophrenia: A systematic review and meta-analysis	7
Refining biomarker evaluation in ASD	7
The U-shaped relationship between parental age and the risk of bipolar disorder in the offspring: A systematic review and meta-analysis	7
Impact of antidepressant use on the autonomic nervous system: A meta-analysis and systematic review	7
Coping under stress: Prefrontal control predicts stress burden during the COVID-19 crisis	7
Neuroimaging evidence for structural correlates in adolescents resilient to polysubstance use: A five-year follow-up study	7
The antipsychotic paradox: Lessons regarding determinants of premature mortality	7
Neurochemical mechanisms of deep brain stimulation for depression in animal models	7
Neural underpinnings of emotion regulation subgroups in remitted patients with recently diagnosed bipolar disorder	7
Early intervention in psychosis during the COVID-19 pandemic: Maudsley recommendations	7
α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects	7
Invisible wounds: Suturing the gap between the neurobiology, conventional and emerging therapies for posttraumatic stress disorder	7
Associations between oxidative stress markers and patient-reported smartphone-based symptoms in patients newly diagnosed with bipolar disorder: An exploratory study	7
Clinical and developmental characteristics of cognitive subgroups in a transdiagnostic sample of schizophrenia spectrum disorders and bipolar disorder	7
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis	7
Integrating genomics and transcriptomics: Towards deciphering ADHD	7
Early intervention comes late	7
THE FEMALE PROTECTIVE EFFECT AGAINST AUTISM SPECTRUM DISORDER	7
Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials - Challenges and future perspectives. A critical review	7
Prevention and treatment of Postpartum Mania, Psychosis, and psychotic depression	7
Monitoring inflammation in psychiatry: Caveats and advice	7
First episode psychosis longitudinal cohort studies: The CIBERSAM FEP cohort	6
Stress, mental disorder and ketamine as a novel, rapid acting treatment	6
Mechanisms of action of anti-bipolar drugs	6
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study	6
Is treatment-resistant depression really resistant?	6
Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?	6
The cognitive anxiety sensitivity treatment (CAST) in anxiety prevention – Focus on separation anxiety and interoception	6
Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence	6
A GWAS top hit for circulating leptin is associated with weight gain but not with leptin protein levels in lithium-augmented patients with major depression	6
Sex-specific associations of basal steroid hormones and neuropeptides with Conduct Disorder and neuroendocrine mediation of environmental risk	6
Noradrenergic stimulation increases fear memory expression	6
The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses	6
Expression of the Transient Receptor Potential Vanilloid 1 ion channel in the supramammillary nucleus and the antidepressant effects of its antagonist AMG9810 in mice	6
REM sleep behavior disorder predicts Parkinson disease and dementia with Lewy bodies	6
Psychopathology for the twenty-first century: Towards a ChatGPT psychopathology?	6
Targeted prevention of anxiety disorders	6
Serum profiling of anorexia nervosa: A 1H NMR-based metabolomics study	6
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms	6
MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans	6
The dynamical association between physical activity and affect in the daily life of individuals with ADHD	6
Anterior cingulate cortex neuro-metabolic changes underlying lithium-induced euthymia in bipolar depression: A longitudinal 1H-MRS study	6
Guanosine boosts the fast, but not sustained, antidepressant-like and pro-synaptogenic effects of ketamine by stimulating mTORC1-driven signaling pathway	6